# Cardiopulmonary-bypass and Reno-protective Effect of Atorvastatin Trial

> **NCT00910221** · PHASE2,PHASE3 · COMPLETED · sponsor: **Austin Health** · enrollment: 100 (actual)

## Conditions studied

- Acute Kidney Dysfunction

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00910221
- **Lead sponsor:** Austin Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-08
- **Final completion:** 2011-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2012-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00910221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00910221, "Cardiopulmonary-bypass and Reno-protective Effect of Atorvastatin Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00910221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*